- Home
- OCGN vs NVX Comparison
OCGN vs NVX Comparison
Compare OCGN & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- NVX
- Stock Information
- Founded
- OCGN 2013
- NVX 2012
- Country
- OCGN United States
- NVX Australia
- Employees
- OCGN N/A
- NVX N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- NVX Industrial Machinery/Components
- Sector
- OCGN Health Care
- NVX Miscellaneous
- Exchange
- OCGN Nasdaq
- NVX Nasdaq
- Market Cap
- OCGN 189.6M
- NVX 174.9M
- IPO Year
- OCGN N/A
- NVX N/A
- Fundamental
- Price
- OCGN $0.70
- NVX $1.14
- Analyst Decision
- OCGN Strong Buy
- NVX Strong Buy
- Analyst Count
- OCGN 3
- NVX 1
- Target Price
- OCGN $6.33
- NVX $4.00
- AVG Volume (30 Days)
- OCGN 4.2M
- NVX 82.0K
- Earning Date
- OCGN 03-05-2025
- NVX 01-01-0001
- Dividend Yield
- OCGN N/A
- NVX N/A
- EPS Growth
- OCGN N/A
- NVX N/A
- EPS
- OCGN N/A
- NVX N/A
- Revenue
- OCGN $4,054,999.00
- NVX $5,854,424.00
- Revenue This Year
- OCGN N/A
- NVX $66.66
- Revenue Next Year
- OCGN N/A
- NVX $2,366.64
- P/E Ratio
- OCGN N/A
- NVX N/A
- Revenue Growth
- OCGN N/A
- NVX N/A
- 52 Week Low
- OCGN $0.52
- NVX $0.97
- 52 Week High
- OCGN $2.08
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- OCGN 53.03
- NVX 43.00
- Support Level
- OCGN $0.69
- NVX $1.24
- Resistance Level
- OCGN $0.80
- NVX $1.31
- Average True Range (ATR)
- OCGN 0.05
- NVX 0.07
- MACD
- OCGN 0.02
- NVX 0.02
- Stochastic Oscillator
- OCGN 58.35
- NVX 22.78
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.